← Back to Search

Thermal Pulsation System

Arm 1 for Meibomian Gland Dysfunction

N/A

Recruiting

Research Sponsored by Periman Eye Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 month

Awards & highlights

Study Summary

This trial tests if a single iLux treatment helps relieve dry eye symptoms and contact lens wearing times.

Eligible Conditions

Meibomian Gland Dysfunction
Dry Eye Syndrome

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 month

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percentage of subjects with dryness symptoms who reported wearing their contact lenses longer, 1 month post treatment.

Percentage of subjects with improvement in CLDEQ8 Questionnaire score from baseline to 1 month

Percentage of subjects with improvement in MGSS from baseline to 1 month

+2 more

Secondary outcome measures

Mean change in Sodium Fluorescein and Lussamine Green staining from baseline to 1 month

Mean change in TBUT from baseline to 1 month

Trial Design

1Treatment groups

Experimental Treatment

Group I: Arm 1Experimental Treatment1 Intervention

Single arm trial

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Periman Eye InstituteLead Sponsor

Alcon ResearchIndustry Sponsor

704 Previous Clinical Trials

124,481 Total Patients Enrolled

3 Trials studying Meibomian Gland Dysfunction

417 Patients Enrolled for Meibomian Gland Dysfunction

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could you provide information on availability for enrolment in this trial?

"Clinicaltrials.gov indicates that this experiment is actively seeking participants. It was originally posted on January 26th 2022, and its details were last modified on November 14th 2023."

Answered by AI

What is the present participant count for this medical experiment?

"Affirmative. The clinical trial is actively accepting patients, as evidenced on the clinicaltrials.gov website where it was initially posted in January of 2022 and modified most recently in November 2023. This study seeks to enrol 30 individuals from one particular medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Evaluating Impact of Systane iLux on Dryness Symptoms and Wearing Time in Contact Lens Users

2022. "Evaluating Impact of Systane iLux on Dryness Symptoms and Wearing Time in Contact Lens Users". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05306561.